SOP Guide for Pharma

Ointments: SOP for Particle Size Reduction in Ointment Manufacturing – V 2.0

SOP for Particle Size Reduction in Ointment Manufacturing – V 2.0

Procedure for Particle Size Reduction in Ointment Manufacturing

Department Production/Quality Assurance (QA)/Research and Development (R&D)
SOP No. SOP/Ointment/026
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to establish a standardized process for reducing the particle size of active pharmaceutical ingredients (APIs) and excipients in ointment manufacturing. Proper particle size reduction enhances uniformity, improves stability, and ensures better product efficacy.

2. Scope

This SOP applies to all personnel involved in the particle size reduction process using mills, homogenizers, or other mechanical size reduction equipment.

3. Responsibilities

  • Production Supervisor: Ensures the particle size reduction process follows defined parameters.
  • Machine Operator: Operates and monitors the milling or homogenization equipment.
  • Quality Assurance (QA) Personnel: Verifies uniformity and compliance with specifications.
  • R&D Scientist: Defines particle size requirements for different formulations.

4. Accountability

The Production and QA Managers are accountable for ensuring that particle size reduction is conducted as per GMP guidelines and documented properly.

5. Procedure

5.1 Pre-Processing Checks

  • Ensure the milling/homogenization equipment is clean and calibrated.
  • Verify that the raw materials are within the required moisture and temperature specifications.
  • Confirm the target particle size distribution from the Batch Manufacturing Record (BMR).

5.2 Selection of Size Reduction Method

  • Ball Milling:
Used for reducing coarse particles.
  • Jet Milling: Used for finer particle reduction without heat generation.
  • High-Shear Homogenization: Used for reducing particle size in liquid formulations.
  • 5.3 Particle Size Reduction Process

    • Feed the materials into the milling/homogenization system.
    • Set the milling parameters such as speed, pressure, and time as per formulation requirements.
    • Monitor the equipment for uniform particle size reduction.

    5.4 Sampling and In-Process Quality Control

    • Take a sample at predefined intervals.
    • Check for particle size distribution using a particle size analyzer.
    • Verify that the particle size is within the acceptable range (e.g., 10-50 microns).

    5.5 Final Verification

    • Inspect for agglomerates or oversized particles.
    • Compare results with standard specifications before proceeding to mixing.

    5.6 Documentation and Approval

    • Record all process parameters in the Particle Size Reduction Log.
    • QA must verify and approve the reduced particle batch before further processing.
    • Label the processed material as “Ready for Use.”

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • R&D – Research and Development
    • BMR – Batch Manufacturing Record

    7. Documents

    • Particle Size Reduction Log (Annexure-1)
    • In-Process Quality Control Report (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • 21 CFR Part 211 – Current Good Manufacturing Practices
    • Equipment Manufacturer Guidelines

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Particle Size Reduction Log

    Date Batch Number Reduction Method Initial Size (µm) Final Size (µm) Verified By
    01/02/2025 SOP/Ointment/001 Jet Milling 100 30 QA Officer
    02/02/2025 SOP/Ointment/002 Ball Milling 200 50 QA Officer

    Annexure-2: In-Process Quality Control Report

    Date Batch Number Test Parameter Specification Result Final Status
    01/02/2025 SOP/Ointment/001 Particle Size Distribution 10-50 µm 30 µm Pass
    02/02/2025 SOP/Ointment/002 Agglomerate Content <1% 0.5% Pass

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    Exit mobile version